Wockhardt Soars 10% After Stellar Q2 Turnaround! 🚀

shares surged over 10% on November 3, 2025, after the pharma major reported a strong Q2 FY26 performance. The company achieved a remarkable turnaround from a net loss to a profit of ₹78 crore, even as revenues saw a slight dip to ₹782 crore. This profit rebound highlighted improved operational efficiency and cost management, reigniting investor confidence in the stock. Market participants cheered the results, driving a sharp rally in WOCKPHARMA shares. The strong comeback signals renewed optimism for the company’s growth trajectory in the coming quarters. 📌 Disclaimer: This content is for information only and not investment advice. Investments in securities market are subject to market risks. Read all the related documents carefully before investing. Please consult a SEBI-registered advisor before making any investment decisions.